Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2026-05-29 @ 12:57 PM
Study NCT ID:
NCT06010303
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-17
First Post:
2023-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sponsor:
BeiGene
Organization: